Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.29 billion.
Market Cap
1.12T
Revenue
105.29B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-39.46%
Dividend Yield
0.04%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.53B | -1.34% | 297,209 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.44B | -1.21% | 258,385 | 14.25B |
| 3 | ARGX | argenx SE | 49.27B | 1.41% | 176,390 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.03B | -0.91% | 268,197 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.52B | -2.21% | 76,263 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.67B | -0.55% | 669,146 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.76B | -2.27% | 365,403 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.61B | 0.73% | 854,437 | - |
| 9 | RPRX | Royalty Pharma plc | 23.06B | -0.65% | 801,049 | 2.35B |
| 10 | GMAB | Genmab A/S | 21.63B | -4.53% | 1,061,891 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.52B | -1.37% | 450,499 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.34B | -1.30% | 1,365,897 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.82B | -0.20% | 4,488,649 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.64B | -2.50% | 1,012,459 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.55B | -0.45% | 734,849 | - |
| 16 | ASND | Ascendis Pharma A/S | 13.33B | -0.05% | 85,376 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.60B | -1.34% | 247,293 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 12.24B | 0.49% | 722,968 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.40B | -0.68% | 68,745 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.94B | 0.08% | 476,823 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.86B | 1.94% | 1,200,321 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -1.77% | 391,772 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.33B | -0.47% | 371,039 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.80B | -5.81% | 1,929,236 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.27B | 2.37% | 555,207 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.84B | -0.90% | 149,304 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.37B | -2.43% | 347,126 | 1.24B |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.32B | 0.52% | 184,900 | 7.46M |
| 29 | NUVL | Nuvalent, Inc. | 8.31B | -0.71% | 175,674 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 8.19B | -3.19% | 83,685 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.79B | -1.42% | 395,297 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.52B | 0.85% | 865,127 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.19B | -4.92% | 198,886 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.35B | - | 200,624 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.14B | -0.98% | 137,718 | 1.78B |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.86B | -2.54% | 150,127 | 43.74M |
| 37 | COGT | Cogent Biosciences, Inc. | 5.85B | 1.75% | 792,616 | - |
| 38 | GPCR | Structure Therapeutics Inc. | 5.81B | -0.36% | 438,833 | - |
| 39 | BLTE | Belite Bio, Inc | 5.79B | 0.42% | 44,421 | - |
| 40 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.64B | -0.67% | 221,315 | 1.54M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.51B | -0.93% | 110,747 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.39B | 1.15% | 343,526 | 209.22M |
| 43 | IMVT | Immunovant, Inc. | 5.31B | -4.13% | 344,148 | - |
| 44 | CRSP | CRISPR Therapeutics AG | 5.26B | -3.01% | 602,006 | 38.34M |
| 45 | CELC | Celcuity Inc. | 5.14B | -3.00% | 147,916 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.72B | 1.43% | 351,729 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.69B | 0.18% | 162,280 | 471.79M |
| 48 | TGTX | TG Therapeutics, Inc. | 4.63B | 7.11% | 2,003,939 | 531.90M |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.09% | 380,980 | 1.05B |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.44B | -0.21% | 896,625 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.37B | -2.47% | 186,016 | 2.17M |
| 52 | ADMA | ADMA Biologics, Inc. | 4.25B | -2.41% | 618,954 | 488.56M |
| 53 | LEGN | Legend Biotech Corporation | 4.14B | -3.69% | 1,131,604 | 909.05M |
| 54 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | -0.66% | 862,701 | - |
| 55 | ACLX | Arcellx, Inc. | 4.01B | -0.66% | 208,341 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.87B | -0.02% | 119,653 | 251.23M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.78B | -2.86% | 448,601 | 741.17M |
| 58 | IBRX | ImmunityBio, Inc. | 3.75B | 25.99% | 40,714,175 | 82.56M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.73B | -3.99% | 2,196,389 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.53B | -2.51% | 448,235 | 35.24M |
| 61 | LQDA | Liquidia Corporation | 3.51B | 0.88% | 1,122,557 | 69.22M |
| 62 | VERA | Vera Therapeutics, Inc. | 3.37B | -1.88% | 168,570 | - |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.29B | 1.86% | 481,778 | 15.00M |
| 64 | BEAM | Beam Therapeutics Inc. | 3.26B | -6.75% | 739,261 | 55.70M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.22B | -1.53% | 335,037 | 317.93M |
| 66 | VRDN | Viridian Therapeutics, Inc. | 3.18B | -1.21% | 284,118 | 70.79M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.18B | -1.97% | 385,905 | 214.83M |
| 68 | XENE | Xenon Pharmaceuticals Inc. | 3.16B | -1.80% | 179,150 | 7.50M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -1.82% | 108,758 | 366.10M |
| 70 | ALMS | Alumis Inc. | 2.98B | -1.73% | 1,235,159 | 22.12M |
| 71 | DNLI | Denali Therapeutics Inc. | 2.92B | 2.35% | 485,203 | - |
| 72 | RCUS | Arcus Biosciences, Inc. | 2.87B | -5.62% | 264,033 | 240.00M |
| 73 | EWTX | Edgewise Therapeutics, Inc. | 2.82B | -5.47% | 640,790 | - |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | -1.51% | 322,849 | 578.20M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.78B | -3.32% | 419,492 | - |
| 76 | ADPT | Adaptive Biotechnologies Corporation | 2.75B | - | 285,896 | 252.75M |
| 77 | IRON | Disc Medicine, Inc. | 2.72B | -6.66% | 978,809 | - |
| 78 | ERAS | Erasca, Inc. | 2.69B | 14.26% | 7,475,691 | - |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.59B | 0.59% | 769,444 | 1.02B |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.58B | -2.62% | 434,050 | - |
| 81 | WVE | Wave Life Sciences Ltd. | 2.57B | -3.10% | 1,259,127 | 109.23M |
| 82 | SYRE | Spyre Therapeutics, Inc. | 2.57B | -0.27% | 173,746 | - |
| 83 | TVTX | Travere Therapeutics, Inc. | 2.53B | -2.25% | 944,218 | 435.83M |
| 84 | TLX | Telix Pharmaceuticals Limited | 2.53B | -1.57% | 131,466 | 664.23M |
| 85 | AAPG | Ascentage Pharma Group International | 2.52B | -2.44% | 1,572 | 54.52M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.46B | -2.47% | 10,179,857 | 43.69M |
| 87 | IMNM | Immunome, Inc. | 2.46B | 7.23% | 1,176,120 | 9.68M |
| 88 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 1.26% | 20,791,610 | 55.78M |
| 89 | MESO | Mesoblast Limited | 2.33B | 0.91% | 74,964 | 17.20M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | -2.68% | 994,188 | 2.41B |
| 91 | SLNO | Soleno Therapeutics, Inc. | 2.26B | -0.71% | 369,245 | 98.68M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.26B | -2.33% | 457,374 | 630.60M |
| 93 | GLPG | Galapagos NV | 2.24B | -0.07% | 59,594 | 336.64M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 2.23B | -1.36% | 234,588 | - |
| 95 | NUVB | Nuvation Bio Inc. | 2.15B | -0.48% | 2,442,882 | 26.75M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.11B | 1.42% | 246,163 | 825.94M |
| 97 | ZLAB | Zai Lab Limited | 2.10B | -3.67% | 404,566 | 441.63M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -2.50% | 449,899 | 265.81M |
| 99 | VCEL | Vericel Corporation | 1.95B | 3.43% | 213,691 | 258.72M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.95B | -1.44% | 65,892 | 2.50M |
| 101 | MBX | MBX Biosciences, Inc. | 1.94B | 0.30% | 539,496 | - |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.90B | -1.63% | 271,049 | 83.69M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.89B | -4.75% | 152,773 | 3.08M |
| 104 | GLUE | Monte Rosa Therapeutics, Inc. | 1.88B | -1.29% | 529,414 | 181.54M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -1.54% | 286,715 | 111.30M |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.78B | 0.89% | 165,431 | 205.63M |
| 107 | ZYME | Zymeworks Inc. | 1.76B | -4.71% | 654,432 | 134.48M |
| 108 | ARDX | Ardelyx, Inc. | 1.75B | 4.57% | 2,699,479 | 398.23M |
| 109 | MNKD | MannKind Corporation | 1.73B | 0.62% | 1,277,945 | 313.79M |
| 110 | SION | Sionna Therapeutics, Inc. | 1.73B | -5.88% | 76,358 | - |
| 111 | KOD | Kodiak Sciences Inc. | 1.73B | -2.72% | 157,548 | - |
| 112 | UPB | Upstream Bio, Inc. | 1.71B | -1.92% | 194,212 | 2.80M |
| 113 | CLDX | Celldex Therapeutics, Inc. | 1.70B | -2.60% | 139,032 | 2.60M |
| 114 | IMCR | Immunocore Holdings plc | 1.66B | -1.12% | 123,756 | 379.59M |
| 115 | TNGX | Tango Therapeutics, Inc. | 1.64B | -1.53% | 1,200,295 | 66.50M |
| 116 | PHVS | Pharvaris N.V. | 1.64B | -1.35% | 61,202 | - |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | -2.44% | 162,791 | 44.79M |
| 118 | NBY | NovaBay Pharmaceuticals, Inc. | 1.62B | 1.14% | 710,324 | 10.30M |
| 119 | BHVN | Biohaven Ltd. | 1.60B | 2.86% | 1,237,927 | - |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.59B | 1.92% | 218,798 | - |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.53B | -1.19% | 101,159 | - |
| 122 | PGEN | Precigen, Inc. | 1.49B | -4.76% | 1,005,044 | 6.31M |
| 123 | FTRE | Fortrea Holdings Inc. | 1.48B | -4.65% | 471,818 | 2.76B |
| 124 | INVA | Innoviva, Inc. | 1.47B | -0.56% | 197,445 | 388.52M |
| 125 | ELVN | Enliven Therapeutics, Inc. | 1.46B | -5.72% | 546,038 | - |
| 126 | SVRA | Savara Inc. | 1.41B | -2.33% | 372,272 | - |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.39B | -4.98% | 217,430 | - |
| 128 | OCS | Oculis Holding AG | 1.39B | 1.35% | 107,630 | 992.00K |
| 129 | NTLA | Intellia Therapeutics, Inc. | 1.38B | -1.00% | 2,582,044 | 57.53M |
| 130 | QURE | uniQure N.V. | 1.38B | -1.23% | 525,844 | 15.75M |
| 131 | TSHA | Taysha Gene Therapies, Inc. | 1.37B | -0.89% | 598,917 | 6.31M |
| 132 | IMTX | Immatics N.V. | 1.36B | 2.85% | 149,237 | 99.45M |
| 133 | RLAY | Relay Therapeutics, Inc. | 1.35B | -3.16% | 776,793 | 8.36M |
| 134 | ATAI | AtaiBeckley Inc. | 1.35B | - | 1,174,577 | 3.02M |
| 135 | EYPT | EyePoint, Inc. | 1.34B | 1.92% | 682,830 | 42.34M |
| 136 | ANAB | AnaptysBio, Inc. | 1.33B | -4.27% | 177,129 | 169.47M |
| 137 | NVAX | Novavax, Inc. | 1.31B | -1.47% | 2,567,854 | 1.06B |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.30B | -0.71% | 117,227 | - |
| 139 | SANA | Sana Biotechnology, Inc. | 1.28B | 1.27% | 1,224,297 | - |
| 140 | ABCL | AbCellera Biologics Inc. | 1.26B | -2.21% | 2,280,195 | 35.33M |
| 141 | PHAR | Pharming Group N.V. | 1.26B | -3.79% | 13,795 | 362.27M |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.24B | -0.17% | 26,890 | - |
| 143 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -3.07% | 834,321 | 11.13M |
| 144 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | -1.72% | 713,372 | 266.14M |
| 145 | SEPN | Septerna, Inc. | 1.23B | 2.99% | 51,184 | 22.05M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.18B | -5.23% | 1,724,805 | - |
| 147 | PHAT | Phathom Pharmaceuticals, Inc. | 1.16B | -1.85% | 322,817 | 147.19M |
| 148 | IVA | Inventiva S.A. | 1.13B | 2.93% | 205,448 | 19.93M |
| 149 | SPRY | ARS Pharmaceuticals, Inc. | 1.11B | -4.41% | 415,061 | 142.77M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | 1.24% | 649,897 | - |
| 151 | AKTS | Aktis Oncology, Inc. | 1.11B | 1.11% | 110,302 | 5.56M |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -9.53% | 569,162 | 15.00M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.09B | -1.22% | 29,197 | 1.40M |
| 154 | DAWN | Day One Biopharmaceuticals, Inc. | 1.08B | -2.33% | 2,103,274 | 133.67M |
| 155 | CMPX | Compass Therapeutics, Inc. | 1.06B | -1.32% | 996,297 | 850.00K |
| 156 | GHRS | GH Research PLC | 1.04B | -0.59% | 37,334 | - |
| 157 | TBPH | Theravance Biopharma, Inc. | 1.03B | -1.53% | 78,474 | 80.33M |
| 158 | NBTX | Nanobiotix S.A. | 1.03B | -2.34% | 17,064 | 11.93M |
| 159 | VTYX | Ventyx Biosciences, Inc. | 995.53M | 0.11% | 758,048 | - |
| 160 | XNCR | Xencor, Inc. | 989.03M | -4.15% | 122,710 | 150.13M |
| 161 | RAPT | RAPT Therapeutics, Inc. | 949.93M | -1.30% | 32,748 | - |
| 162 | BCAX | Bicara Therapeutics Inc. | 940.61M | -4.72% | 157,073 | - |
| 163 | MRVI | Maravai LifeSciences Holdings, Inc. | 938.44M | -6.85% | 853,006 | 192.44M |
| 164 | ANNX | Annexon, Inc. | 937.56M | -5.84% | 1,049,559 | - |
| 165 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 936.27M | -2.78% | 35,609 | - |
| 166 | IOVA | Iovance Biotherapeutics, Inc. | 915.01M | -3.15% | 5,566,104 | 250.43M |
| 167 | ABUS | Arbutus Biopharma Corporation | 913.54M | -0.63% | 262,748 | 14.61M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 903.24M | -2.63% | 63,120 | - |
| 169 | VIR | Vir Biotechnology, Inc. | 901.53M | -4.99% | 572,375 | 16.86M |
| 170 | VALN | Valneva SE | 892.29M | -4.82% | 33,727 | 211.09M |
| 171 | DRUG | Bright Minds Biosciences Inc. | 890.34M | -1.71% | 33,544 | - |
| 172 | URGN | UroGen Pharma Ltd. | 888.90M | 1.33% | 381,930 | 96.52M |
| 173 | OMER | Omeros Corporation | 858.25M | -7.45% | 1,250,109 | - |
| 174 | MDXG | MiMedx Group, Inc. | 851.59M | 1.05% | 260,469 | 393.44M |
| 175 | GERN | Geron Corporation | 833.05M | -3.33% | 3,606,970 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 824.02M | -2.97% | 462,317 | 10.00M |
| 177 | YDES | YD Bio Limited | 814.30M | -1.86% | 64,259 | 510.36K |
| 178 | KURA | Kura Oncology, Inc. | 792.73M | -2.67% | 355,924 | 104.03M |
| 179 | ARVN | Arvinas, Inc. | 780.97M | -0.33% | 248,460 | 312.30M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 778.34M | -4.93% | 51,028 | - |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 757.69M | -1.64% | 178,066 | 1.43M |
| 182 | RGNX | REGENXBIO Inc. | 734.03M | -3.01% | 317,023 | 161.32M |
| 183 | CTMX | CytomX Therapeutics, Inc. | 726.88M | -0.23% | 665,487 | 113.63M |
| 184 | ATXS | Astria Therapeutics, Inc. | 717.27M | 0.20% | 188,808 | 706.00K |
| 185 | NKTR | Nektar Therapeutics | 714.19M | -2.72% | 237,788 | 62.60M |
| 186 | DBVT | DBV Technologies S.A. | 713.07M | 2.77% | 88,254 | 5.50M |
| 187 | PRME | Prime Medicine, Inc. | 709.92M | -6.96% | 2,232,481 | 5.98M |
| 188 | GYRE | Gyre Therapeutics, Inc. | 706.22M | 1.04% | 10,295 | 107.27M |
| 189 | IVVD | Invivyd, Inc. | 697.92M | -4.81% | 983,320 | 50.04M |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 696.47M | -1.92% | 101,212 | 282.08M |
| 191 | JBIO | Jade Biosciences, Inc. | 672.12M | -0.34% | 39,061 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 668.94M | -2.12% | 198,132 | 80.00M |
| 193 | PROK | ProKidney Corp. | 660.33M | -3.73% | 615,094 | 744.00K |
| 194 | SLS | SELLAS Life Sciences Group, Inc. | 656.44M | -6.20% | 3,354,782 | - |
| 195 | DRTS | Alpha Tau Medical Ltd. | 655.68M | 2.53% | 437,600 | - |
| 196 | TENX | Tenax Therapeutics, Inc. | 637.36M | -14.01% | 405,127 | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 635.66M | -1.01% | 194,101 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 614.15M | 2.42% | 186,650 | 27.42M |
| 199 | ENGN | enGene Holdings Inc. | 604.20M | -0.88% | 44,781 | - |
| 200 | EVMN | Evommune, Inc. | 604.00M | -9.84% | 44,021 | 13.00M |
| 201 | KROS | Keros Therapeutics, Inc. | 588.30M | -1.13% | 72,551 | 246.72M |
| 202 | VOR | Vor Biopharma Inc. | 581.19M | 1.62% | 461,058 | - |
| 203 | REPL | Replimune Group, Inc. | 578.91M | -4.28% | 522,561 | - |
| 204 | FBRX | Forte Biosciences, Inc. | 575.60M | 0.59% | 39,366 | - |
| 205 | GOSS | Gossamer Bio, Inc. | 571.70M | -3.14% | 1,012,343 | 44.05M |
| 206 | LENZ | LENZ Therapeutics, Inc. | 570.89M | -1.86% | 573,131 | 17.50M |
| 207 | LXEO | Lexeo Therapeutics, Inc. | 556.89M | -1.17% | 224,046 | - |
| 208 | CRMD | CorMedix Inc. | 554.67M | -0.71% | 1,584,259 | 214.30M |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 549.04M | -1.93% | 293,729 | 180.61M |
| 210 | DSGN | Design Therapeutics, Inc. | 546.00M | -2.19% | 280,538 | - |
| 211 | OCGN | Ocugen, Inc. | 534.07M | -9.04% | 6,485,099 | 5.37M |
| 212 | VSTM | Verastem, Inc. | 531.78M | 1.47% | 982,952 | 13.38M |
| 213 | CRVS | Corvus Pharmaceuticals, Inc. | 528.00M | 3.67% | 572,044 | - |
| 214 | ANRO | Alto Neuroscience, Inc. | 521.45M | -2.19% | 24,783 | - |
| 215 | ZVRA | Zevra Therapeutics, Inc. | 510.62M | -1.09% | 274,606 | 84.39M |
| 216 | LBRX | LB Pharmaceuticals Inc | 504.21M | 2.94% | 68,981 | - |
| 217 | NAGE | Niagen Bioscience, Inc. | 503.76M | -0.32% | 253,471 | 124.71M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 497.60M | -4.91% | 339,980 | - |
| 219 | PRTA | Prothena Corporation plc | 488.78M | -1.30% | 131,653 | 11.79M |
| 220 | LYEL | Lyell Immunopharma, Inc. | 482.45M | -3.20% | 37,444 | 41.00K |
| 221 | ABSI | Absci Corporation | 479.69M | -4.78% | 1,877,027 | 2.82M |
| 222 | ASMB | Assembly Biosciences, Inc. | 474.67M | -6.34% | 15,845 | 37.19M |
| 223 | ALT | Altimmune, Inc. | 472.64M | 3.59% | 2,331,572 | 20.00K |
| 224 | VTVT | vTv Therapeutics Inc. | 470.54M | -5.22% | 5,884 | 17.00K |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 469.65M | -6.16% | 254,429 | 120.00K |
| 226 | LXRX | Lexicon Pharmaceuticals, Inc. | 454.25M | 0.81% | 436,765 | 70.86M |
| 227 | DMAC | DiaMedica Therapeutics Inc. | 453.27M | -1.63% | 80,732 | - |
| 228 | SLDB | Solid Biosciences Inc. | 452.27M | -0.09% | 290,956 | - |
| 229 | ADCT | ADC Therapeutics SA | 449.67M | -2.16% | 155,484 | 75.21M |
| 230 | IMMP | Immutep Limited | 448.31M | -2.26% | 58,567 | 3.31M |
| 231 | BCYC | Bicycle Therapeutics plc | 448.12M | -2.42% | 86,984 | 28.34M |
| 232 | VNDA | Vanda Pharmaceuticals Inc. | 445.88M | -2.01% | 408,520 | 212.07M |
| 233 | NBP | NovaBridge Biosciences | 441.56M | 8.50% | 380,994 | - |
| 234 | MNPR | Monopar Therapeutics Inc. | 439.11M | -5.59% | 205,264 | - |
| 235 | PRTC | PureTech Health plc | 438.83M | 0.79% | 3,356 | 6.39M |
| 236 | AVXL | Anavex Life Sciences Corp. | 427.98M | -0.62% | 451,897 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 427.10M | 4.86% | 28,357 | - |
| 238 | RCKT | Rocket Pharmaceuticals, Inc. | 408.54M | -4.67% | 858,718 | - |
| 239 | GLSI | Greenwich LifeSciences, Inc. | 408.36M | 0.63% | 321,206 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 407.11M | -1.18% | 295,893 | 10.82M |
| 241 | HELP | Cybin Inc. | 403.18M | -0.75% | 194,410 | - |
| 242 | CTNM | Contineum Therapeutics, Inc. | 402.92M | -6.21% | 51,134 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 398.90M | -2.89% | 49,518 | - |
| 244 | TRDA | Entrada Therapeutics, Inc. | 396.27M | 4.44% | 98,984 | 61.52M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 395.85M | -0.90% | 83,423 | 65.32M |
| 246 | AUTL | Autolus Therapeutics plc | 384.58M | 1.76% | 976,416 | 51.13M |
| 247 | ALLO | Allogene Therapeutics, Inc. | 373.05M | -2.35% | 2,120,488 | 22.00K |
| 248 | TECX | Tectonic Therapeutic, Inc. | 370.02M | 0.51% | 116,141 | - |
| 249 | FHTX | Foghorn Therapeutics Inc. | 369.94M | 0.08% | 63,903 | 24.52M |
| 250 | ACIU | AC Immune SA | 367.08M | 1.09% | 278,510 | 5.48M |
| 251 | XOMA | XOMA Royalty Corporation | 353.66M | -2.72% | 760,611 | 47.11M |
| 252 | PEPG | PepGen Inc. | 349.93M | -1.17% | 240,050 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 346.67M | -5.12% | 341,236 | - |
| 254 | CADL | Candel Therapeutics, Inc. | 334.33M | -1.93% | 419,577 | - |
| 255 | AURA | Aura Biosciences, Inc. | 328.31M | -1.71% | 41,631 | - |
| 256 | AARD | Aardvark Therapeutics, Inc. | 325.95M | -0.07% | 48,964 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 322.76M | -0.23% | 133,425 | 212.00M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 320.02M | -2.92% | 265,057 | 33.98M |
| 259 | ZURA | Zura Bio Limited | 309.51M | -11.36% | 204,424 | - |
| 260 | IMRX | Immuneering Corporation | 301.54M | 5.42% | 996,856 | - |
| 261 | CLLS | Cellectis S.A. | 298.37M | -2.34% | 9,369 | 82.55M |
| 262 | ACHV | Achieve Life Sciences, Inc. | 297.58M | -0.36% | 124,240 | - |
| 263 | AVTX | Avalo Therapeutics, Inc. | 296.94M | -0.93% | 83,534 | 192.00K |
| 264 | CAMP | Camp4 Therapeutics Corporation | 294.68M | -4.05% | 34,094 | 3.80M |
| 265 | ABEO | Abeona Therapeutics Inc. | 293.72M | 4.43% | 698,299 | 400.00K |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 292.53M | -1.46% | 202,538 | 15.74M |
| 267 | AVIR | Atea Pharmaceuticals, Inc. | 282.82M | 2.26% | 213,294 | - |
| 268 | LRMR | Larimar Therapeutics, Inc. | 282.45M | -3.23% | 331,497 | - |
| 269 | RLMD | Relmada Therapeutics, Inc. | 280.87M | -0.26% | 203,213 | - |
| 270 | NGNE | Neurogene Inc. | 280.68M | -3.62% | 68,075 | 925.00K |
| 271 | STTK | Shattuck Labs, Inc. | 279.70M | -6.55% | 121,031 | 1.00M |
| 272 | GUTS | Fractyl Health, Inc. | 275.46M | - | 1,150,167 | 3.00K |
| 273 | HRTX | Heron Therapeutics, Inc. | 275.04M | 0.67% | 348,657 | 155.10M |
| 274 | TARA | Protara Therapeutics, Inc. | 274.90M | 3.85% | 542,242 | - |
| 275 | PALI | Palisade Bio, Inc. | 274.17M | -5.64% | 2,489,555 | - |
| 276 | MENS | Jyong Biotech Ltd. | 273.76M | 3.79% | 236,197 | - |
| 277 | OABI | OmniAb, Inc. | 272.80M | -0.79% | 43,713 | 21.09M |
| 278 | SLN | Silence Therapeutics plc | 271.12M | -2.21% | 75,001 | 25.83M |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 261.96M | 1.19% | 24,391 | 38.79M |
| 280 | ALDX | Aldeyra Therapeutics, Inc. | 256.29M | 0.47% | 212,010 | - |
| 281 | RZLT | Rezolute, Inc. | 254.07M | 0.74% | 1,394,582 | - |
| 282 | IMMX | Immix Biopharma, Inc. | 253.99M | -2.82% | 338,457 | - |
| 283 | CBIO | Crescent Biopharma, Inc. | 243.00M | -1.58% | 24,358 | - |
| 284 | ARMP | Armata Pharmaceuticals, Inc. | 234.46M | 12.98% | 51,016 | 5.05M |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 233.76M | -7.17% | 104,535 | 2.82M |
| 286 | ENLV | Enlivex Therapeutics Ltd. | 233.65M | 1.84% | 324,667 | - |
| 287 | NAUT | Nautilus Biotechnology, Inc. | 232.40M | -4.17% | 98,105 | - |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 231.16M | -0.59% | 133,193 | 1.00 |
| 289 | VYGR | Voyager Therapeutics, Inc. | 227.13M | -1.09% | 253,087 | 31.32M |
| 290 | MDWD | MediWound Ltd. | 221.04M | 1.17% | 30,096 | 20.93M |
| 291 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.65M | -0.91% | 168,618 | 97.60M |
| 292 | ZNTL | Zentalis Pharmaceuticals, Inc. | 216.92M | -4.56% | 803,956 | 26.87M |
| 293 | CCCC | C4 Therapeutics, Inc. | 216.12M | -4.29% | 396,401 | 30.11M |
| 294 | HUMA | Humacyte, Inc. | 214.23M | -2.63% | 2,218,447 | 1.57M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 214.14M | -0.59% | 9,456 | - |
| 296 | EDIT | Editas Medicine, Inc. | 206.95M | -4.50% | 1,025,678 | 46.38M |
| 297 | CGEN | Compugen Ltd. | 206.71M | 11.62% | 1,051,975 | 6.90M |
| 298 | OVID | Ovid Therapeutics Inc. | 206.34M | -3.94% | 641,583 | 6.61M |
| 299 | GALT | Galectin Therapeutics Inc. | 206.31M | 6.67% | 210,396 | - |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 206.21M | - | 1,729,689 | - |
| 301 | CABA | Cabaletta Bio, Inc. | 205.04M | -0.93% | 501,558 | - |
| 302 | SGMT | Sagimet Biosciences Inc. | 204.89M | -1.10% | 84,885 | - |
| 303 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.65M | -5.62% | 224,903 | 10.30M |
| 304 | CHRS | Coherus Oncology, Inc. | 197.02M | 1.87% | 549,373 | 277.73M |
| 305 | ALEC | Alector, Inc. | 196.47M | -2.70% | 858,466 | 69.05M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 194.67M | 3.08% | 11,997 | 18.97M |
| 307 | RNAC | Cartesian Therapeutics, Inc. | 191.13M | -3.80% | 24,169 | 1.09M |
| 308 | NERV | Minerva Neurosciences, Inc. | 189.11M | 1.39% | 38,913 | - |
| 309 | CRDF | Cardiff Oncology, Inc. | 188.27M | -0.53% | 176,465 | 501.00K |
| 310 | IPSC | Century Therapeutics, Inc. | 187.72M | 6.44% | 1,470,434 | 113.34M |
| 311 | SABS | SAB Biotherapeutics, Inc. | 187.33M | -1.62% | 80,646 | 114.70K |
| 312 | CLYM | Climb Bio, Inc. | 187.16M | -1.01% | 139,774 | - |
| 313 | PRLD | Prelude Therapeutics Incorporated | 177.15M | -4.87% | 130,269 | 10.50M |
| 314 | PRQR | ProQR Therapeutics N.V. | 175.40M | 1.52% | 124,782 | 18.86M |
| 315 | NTHI | NeOnc Technologies Holdings, Inc. | 172.25M | -5.30% | 31,132 | 59.99K |
| 316 | SRZN | Surrozen, Inc. | 170.23M | -0.70% | 7,711 | 3.60M |
| 317 | RANI | Rani Therapeutics Holdings, Inc. | 169.52M | -0.36% | 453,212 | 1.20M |
| 318 | KLRS | Kalaris Therapeutics, Inc. | 167.76M | -2.92% | 48,865 | - |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 166.07M | 0.24% | 192,167 | 61.84M |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 165.58M | 0.98% | 1,040,943 | - |
| 321 | QNCX | Quince Therapeutics, Inc. | 164.82M | -1.66% | 555,595 | - |
| 322 | ELDN | Eledon Pharmaceuticals, Inc. | 164.26M | 1.97% | 288,591 | - |
| 323 | TLSA | Tiziana Life Sciences Ltd | 163.98M | -6.12% | 78,733 | - |
| 324 | IPHA | Innate Pharma S.A. | 162.21M | 0.11% | 3,749 | 14.84M |
| 325 | CDXS | Codexis, Inc. | 160.78M | - | 151,965 | 52.93M |
| 326 | MOLN | Molecular Partners AG | 155.88M | 1.19% | 2,438 | 856.30K |
| 327 | BDTX | Black Diamond Therapeutics, Inc. | 152.98M | -3.76% | 212,920 | 70.00M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 151.01M | -1.33% | 63,036 | - |
| 329 | CRBU | Caribou Biosciences, Inc. | 148.15M | -1.55% | 517,345 | 9.30M |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 145.63M | -0.05% | 1,742,343 | 32.88M |
| 331 | VXRT | Vaxart, Inc. | 143.76M | 9.12% | 652,790 | 148.20M |
| 332 | IRD | Opus Genetics, Inc. | 143.45M | -4.15% | 72,970 | 14.63M |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 142.49M | -1.65% | 320,410 | 2.00M |
| 334 | NKTX | Nkarta, Inc. | 142.41M | -3.14% | 386,314 | - |
| 335 | TTRX | Turn Therapeutics Inc. | 141.34M | 1.27% | 10,875 | - |
| 336 | CNTX | Context Therapeutics Inc. | 140.58M | -2.55% | 391,093 | - |
| 337 | ELTX | Elicio Therapeutics, Inc. | 140.32M | - | 12,026 | - |
| 338 | MCRB | Seres Therapeutics, Inc. | 140.13M | -3.67% | 18,852 | 351.00K |
| 339 | WHWK | Whitehawk Therapeutics, Inc. | 136.67M | - | 51,754 | 14.38M |
| 340 | SPRO | Spero Therapeutics, Inc. | 135.78M | -3.98% | 82,000 | 40.55M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 134.75M | -5.14% | 361,286 | - |
| 342 | ACOG | Alpha Cognition Inc. | 128.84M | -0.07% | 22,911 | 7.43M |
| 343 | AGEN | Agenus Inc. | 127.19M | -20.09% | 2,323,032 | 106.83M |
| 344 | VRCA | Verrica Pharmaceuticals Inc. | 126.16M | -0.75% | 70,542 | 30.83M |
| 345 | CNTB | Connect Biopharma Holdings Limited | 125.22M | 2.75% | 12,324 | 762.00K |
| 346 | KPTI | Karyopharm Therapeutics Inc. | 124.69M | -5.29% | 214,727 | 142.53M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 122.70M | -2.11% | 346,064 | - |
| 348 | FATE | Fate Therapeutics, Inc. | 121.70M | -2.31% | 525,317 | 7.14M |
| 349 | ACTU | Actuate Therapeutics, Inc. | 119.47M | -2.28% | 41,529 | - |
| 350 | PYXS | Pyxis Oncology, Inc. | 116.43M | -6.03% | 638,246 | 2.82M |
| 351 | GNLX | Genelux Corporation | 112.93M | -2.30% | 117,170 | 8.00K |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 111.76M | 3.07% | 75,166 | - |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 111.64M | -0.91% | 389,084 | 182.34K |
| 354 | ARTV | Artiva Biotherapeutics, Inc. | 111.19M | -5.23% | 94,937 | 251.00K |
| 355 | RPTX | Repare Therapeutics Inc. | 111.00M | -0.96% | 117,311 | 11.87M |
| 356 | MGNX | MacroGenics, Inc. | 110.70M | -1.69% | 233,501 | 127.63M |
| 357 | THAR | Tharimmune, Inc. | 110.29M | -3.59% | 219,465 | - |
| 358 | ANIX | Anixa Biosciences, Inc. | 110.14M | -0.30% | 139,406 | - |
| 359 | STRO | Sutro Biopharma, Inc. | 108.37M | 0.47% | 58,499 | 105.65M |
| 360 | ONCY | Oncolytics Biotech Inc. | 108.14M | -4.29% | 677,676 | - |
| 361 | MREO | Mereo BioPharma Group plc | 107.70M | -5.55% | 12,460,359 | 500.00K |
| 362 | FBIO | Fortress Biotech, Inc. | 105.84M | 3.96% | 737,176 | 62.30M |
| 363 | SEER | Seer, Inc. | 105.75M | -2.08% | 63,569 | 16.38M |
| 364 | BMEA | Biomea Fusion, Inc. | 104.29M | -8.95% | 1,646,333 | - |
| 365 | ETHZ | ETHZilla Corporation | 103.81M | 0.92% | 261,406 | 4.11M |
| 366 | CBUS | Cibus, Inc. | 103.57M | -2.05% | 53,117 | 3.79M |
| 367 | SAVA | Cassava Sciences, Inc. | 103.14M | -0.70% | 184,332 | - |
| 368 | CSBR | Champions Oncology, Inc. | 102.04M | 2.34% | 3,333 | 58.42M |
| 369 | HYFT | MindWalk Holdings Corp. | 95.95M | -3.97% | 285,535 | 19.02M |
| 370 | DTIL | Precision BioSciences, Inc. | 94.36M | -5.08% | 154,379 | 698.00K |
| 371 | VANI | Vivani Medical, Inc. | 93.05M | 0.43% | 110,225 | - |
| 372 | OKYO | OKYO Pharma Limited | 91.77M | -13.78% | 185,606 | - |
| 373 | EXOZ | eXoZymes, Inc. | 88.90M | -1.58% | - | -700.00 |
| 374 | ADAG | Adagene Inc. | 88.51M | 4.33% | 45,291 | 103.20K |
| 375 | ANVS | Annovis Bio, Inc. | 85.60M | 1.89% | 160,366 | - |
| 376 | DWTX | Dogwood Therapeutics, Inc. | 84.72M | -1.72% | 16,205 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 83.70M | -13.79% | 648,335 | 3.99M |
| 378 | KRRO | Korro Bio, Inc. | 83.11M | -1.94% | 36,543 | 7.37M |
| 379 | ACET | Adicet Bio, Inc. | 81.86M | -2.29% | 62,797 | - |
| 380 | SPRB | Spruce Biosciences, Inc. | 81.52M | -2.82% | 5,290 | 697.00K |
| 381 | COEP | Coeptis Therapeutics Holdings, Inc. | 79.64M | -0.78% | 44,943 | 501.00K |
| 382 | MNOV | MediciNova, Inc. | 79.62M | 12.50% | 289,878 | 257.92K |
| 383 | PLRX | Pliant Therapeutics, Inc. | 79.27M | -1.53% | 554,722 | - |
| 384 | GANX | Gain Therapeutics, Inc. | 79.23M | -6.36% | 650,199 | - |
| 385 | PTHS | Pelthos Therapeutics Inc. | 78.82M | 1.73% | 6,970 | 7.41M |
| 386 | XBIT | XBiotech Inc. | 77.13M | -3.07% | 45,049 | - |
| 387 | IMUX | Immunic, Inc. | 76.93M | -1.60% | 928,227 | - |
| 388 | KZIA | Kazia Therapeutics Limited | 76.82M | 3.07% | 399,772 | 1.20M |
| 389 | CALC | CalciMedica, Inc. | 76.80M | -2.56% | 19,010 | - |
| 390 | ATOS | Atossa Therapeutics, Inc. | 76.21M | -1.99% | 704,867 | - |
| 391 | ENTX | Entera Bio Ltd. | 74.29M | -0.61% | 19,459 | 124.00K |
| 392 | PYPD | PolyPid Ltd. | 73.19M | 1.38% | 98,007 | - |
| 393 | IMA | ImageneBio, Inc. | 71.66M | -1.49% | 8,148 | 800.00K |
| 394 | ALXO | ALX Oncology Holdings Inc. | 70.48M | -2.26% | 136,039 | - |
| 395 | ATYR | aTyr Pharma, Inc. | 70.00M | -0.49% | 407,323 | 190.00K |
| 396 | IFRX | InflaRx N.V. | 69.44M | -4.21% | 234,386 | 73.73K |
| 397 | BYSI | BeyondSpring Inc. | 68.47M | -0.30% | 9,031 | 1.88M |
| 398 | TVGN | Tevogen Bio Holdings Inc. | 66.68M | 5.57% | 331,480 | - |
| 399 | TCRX | TScan Therapeutics, Inc. | 66.68M | -2.08% | 201,742 | 8.42M |
| 400 | CRVO | CervoMed Inc. | 66.48M | 2.79% | 26,744 | 6.16M |
| 401 | EQ | Equillium, Inc. | 65.76M | -6.09% | 169,063 | 4.39M |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 64.54M | 1.40% | 843,352 | 242.00K |
| 403 | LPCN | Lipocine Inc. | 64.04M | 4.86% | 258,142 | 4.32M |
| 404 | MGX | Metagenomi Therapeutics, Inc. | 63.45M | -2.31% | 99,715 | 30.91M |
| 405 | RADX | Radiopharm Theranostics Limited | 61.61M | 0.14% | 32,228 | 8.20M |
| 406 | ANL | Adlai Nortye Ltd. | 60.89M | 2.48% | 20,662 | -1.35M |
| 407 | MAIA | MAIA Biotechnology, Inc. | 60.84M | -3.64% | 125,563 | - |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.66M | - | 100,595 | - |
| 409 | ICCC | ImmuCell Corporation | 60.55M | 1.11% | 2,091 | 27.77M |
| 410 | ACRV | Acrivon Therapeutics, Inc. | 59.64M | 3.28% | 676,929 | - |
| 411 | ATHE | Alterity Therapeutics Limited | 58.38M | 0.54% | 1,314 | 3.57M |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.79M | 0.82% | 35,032 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 53.14M | -3.41% | 5,839 | - |
| 414 | LITS | Lite Strategy, Inc. | 52.95M | -7.10% | 478,626 | - |
| 415 | ALGS | Aligos Therapeutics, Inc. | 52.92M | -4.97% | 46,286 | 2.65M |
| 416 | PDSB | PDS Biotechnology Corporation | 52.57M | -2.50% | 203,913 | - |
| 417 | OSTX | OS Therapies Incorporated | 52.47M | -3.87% | 1,290,079 | - |
| 418 | NTRB | Nutriband Inc. | 52.27M | 1.18% | 423 | 2.28M |
| 419 | IBO | Impact BioMedical Inc. | 51.26M | 1.24% | 10,594 | 25.00K |
| 420 | NRXS | NeurAxis, Inc. | 50.39M | -0.21% | 6,903 | 3.36M |
| 421 | IBIO | iBio, Inc. | 50.37M | -10.04% | 1,332,826 | 500.00K |
| 422 | ABVC | ABVC BioPharma, Inc. | 49.50M | 0.96% | 31,038 | 797.92K |
| 423 | TIL | Instil Bio, Inc. | 48.36M | -0.83% | 27,145 | - |
| 424 | PASG | Passage Bio, Inc. | 48.16M | -0.07% | 28,884 | - |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 47.45M | 2.22% | 70,305 | - |
| 426 | PTN | Palatin Technologies, Inc. | 47.18M | 2.68% | 24,612 | 8.85M |
| 427 | NXTC | NextCure, Inc. | 45.78M | 0.77% | 7,879 | - |
| 428 | HURA | TuHURA Biosciences, Inc. | 45.55M | -0.89% | 126,630 | - |
| 429 | KZR | Kezar Life Sciences, Inc. | 45.48M | 0.65% | 10,592 | - |
| 430 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.19M | -0.90% | 10,467 | - |
| 431 | APLM | Apollomics, Inc. | 44.25M | 4.04% | 967 | 6.93M |
| 432 | QTTB | Q32 Bio Inc. | 44.17M | -0.28% | 41,890 | - |
| 433 | OKUR | OnKure Therapeutics, Inc. | 43.08M | -0.31% | 12,504 | - |
| 434 | XLO | Xilio Therapeutics, Inc. | 42.96M | -1.50% | 178,829 | 31.80M |
| 435 | TVRD | Tvardi Therapeutics, Inc. | 42.92M | -1.19% | 29,787 | - |
| 436 | CVM | CEL-SCI Corporation | 42.42M | -4.27% | 47,476 | - |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 42.11M | 1.50% | 66,658 | 90.00K |
| 438 | JSPR | Jasper Therapeutics, Inc. | 41.70M | -8.02% | 518,380 | - |
| 439 | ESLA | Estrella Immunopharma, Inc. | 41.19M | -5.77% | 28,807 | - |
| 440 | INMB | INmune Bio, Inc. | 41.07M | 0.32% | 249,511 | 50.00K |
| 441 | EVAX | Evaxion A/S | 40.89M | -3.11% | 19,384 | 7.65M |
| 442 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.75M | -2.80% | 1,275,194 | - |
| 443 | XCUR | Exicure, Inc. | 39.26M | 2.67% | 57,799 | 500.00K |
| 444 | IOBT | IO Biotech, Inc. | 38.95M | 0.99% | 162,938 | - |
| 445 | VERU | Veru Inc. | 38.84M | 3.42% | 77,015 | 16.89M |
| 446 | LTRN | Lantern Pharma Inc. | 38.81M | -1.98% | 8,175 | - |
| 447 | CELU | Celularity Inc. | 38.58M | 0.60% | 2,317 | 40.58M |
| 448 | PSTV | Plus Therapeutics, Inc. | 38.39M | -3.81% | 16,480,609 | 5.26M |
| 449 | GLTO | Galecto, Inc. | 38.28M | -3.96% | 5,953 | - |
| 450 | GBIO | Generation Bio Co. | 38.27M | 0.35% | 21,046 | 15.27M |
| 451 | RNXT | RenovoRx, Inc. | 37.75M | -2.83% | 81,229 | 928.00K |
| 452 | CING | Cingulate Inc. | 37.64M | 5.65% | 69,741 | - |
| 453 | ATRA | Atara Biotherapeutics, Inc. | 36.34M | 12.75% | 708,926 | 151.93M |
| 454 | ANTX | AN2 Therapeutics, Inc. | 35.62M | -0.76% | 16,073 | - |
| 455 | OTLK | Outlook Therapeutics, Inc. | 33.67M | -2.74% | 2,106,735 | 1.41M |
| 456 | DYAI | Dyadic International, Inc. | 32.91M | 3.40% | 21,827 | 3.34M |
| 457 | GNTA | Genenta Science S.p.A. | 32.34M | 0.73% | 13,123 | - |
| 458 | SKYE | Skye Bioscience, Inc. | 31.28M | -4.34% | 208,096 | - |
| 459 | LIXT | Lixte Biotechnology Holdings, Inc. | 30.97M | -0.56% | 10,023 | - |
| 460 | MRKR | Marker Therapeutics, Inc. | 30.51M | 0.55% | 195,160 | 4.69M |
| 461 | RNTX | Rein Therapeutics Inc. | 30.49M | 3.57% | 93,009 | - |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 30.29M | -4.67% | 219,970 | - |
| 463 | SER | Serina Therapeutics, Inc. | 30.07M | 5.62% | 13,604 | 116.00K |
| 464 | BRNS | Barinthus Biotherapeutics plc | 29.81M | -3.29% | 57,311 | 14.97M |
| 465 | HYPD | Hyperion DeFi, Inc. | 29.39M | -1.41% | 77,490 | 345.32K |
| 466 | JUNS | Jupiter Neurosciences, Inc. | 29.00M | 4.00% | 43,716 | - |
| 467 | RLYB | Rallybio Corporation | 28.95M | 0.01% | 17,413 | 674.00K |
| 468 | IGC | IGC Pharma, Inc. | 28.17M | -1.90% | 180,337 | 1.11M |
| 469 | DARE | Daré Bioscience, Inc. | 28.15M | -2.96% | 25,178 | -57.13K |
| 470 | SNTI | Senti Biosciences, Inc. | 28.13M | -2.73% | 131,867 | - |
| 471 | BOLD | Boundless Bio, Inc. | 27.98M | -0.79% | 31,111 | - |
| 472 | PLUR | Pluri Inc. | 27.77M | -1.95% | 1,290 | 1.33M |
| 473 | QNTM | Quantum BioPharma Ltd. | 27.64M | -0.78% | 29,443 | - |
| 474 | HOWL | Werewolf Therapeutics, Inc. | 26.94M | -5.01% | 234,552 | 1.14M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 26.58M | -4.06% | 623,963 | 721.00K |
| 476 | CUE | Cue Biopharma, Inc. | 25.98M | -16.51% | 1,038,506 | 7.10M |
| 477 | LONA | LeonaBio, Inc. | 25.40M | -2.13% | 8,798 | - |
| 478 | INTS | Intensity Therapeutics, Inc. | 25.17M | -1.41% | 213,838 | - |
| 479 | NNVC | NanoViricides, Inc. | 24.59M | -0.87% | 65,522 | - |
| 480 | PLRZ | Polyrizon Ltd. | 23.89M | -0.73% | 32,910 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 23.26M | 4.77% | 561,728 | - |
| 482 | FBLG | FibroBiologics, Inc. | 22.56M | -0.29% | 597,618 | - |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 22.15M | 1.98% | 6,655 | 15.65M |
| 484 | LNAI | Lunai Bioworks Inc. | 21.31M | -5.47% | 119,222 | - |
| 485 | CASI | CASI Pharmaceuticals, Inc. | 21.16M | 0.98% | 256,958 | 26.85M |
| 486 | LIMN | Liminatus Pharma, Inc. | 20.77M | 2.33% | 41,385 | - |
| 487 | CLGN | CollPlant Biotechnologies Ltd. | 20.51M | -3.89% | 2,317 | 2.48M |
| 488 | ALLR | Allarity Therapeutics, Inc. | 20.49M | -2.50% | 36,918 | - |
| 489 | KTTA | Pasithea Therapeutics Corp. | 19.67M | -3.22% | 88,228 | - |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 19.25M | -1.98% | 19,244 | - |
| 491 | VYNE | VYNE Therapeutics Inc. | 19.17M | 1.62% | 121,321 | 524.00K |
| 492 | LSTA | Lisata Therapeutics, Inc. | 19.05M | 3.85% | 30,141 | 1.07M |
| 493 | BCAB | BioAtla, Inc. | 18.89M | -5.60% | 1,091,054 | 11.00M |
| 494 | OSRH | OSR Holdings, Inc. | 18.15M | -3.69% | 687,228 | -90.52K |
| 495 | KAPA | Kairos Pharma, Ltd. | 17.86M | -0.24% | 38,766 | - |
| 496 | PMN | ProMIS Neurosciences, Inc. | 17.78M | 1.47% | 2,129 | - |
| 497 | KALA | KALA BIO, Inc. | 17.45M | -2.39% | 280,619 | - |
| 498 | LEXX | Lexaria Bioscience Corp. | 17.43M | -10.45% | 131,020 | 522.00K |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 17.40M | -2.86% | 60,813 | - |
| 500 | ITRM | Iterum Therapeutics plc | 16.89M | -1.96% | 168,463 | 390.00K |
| 501 | HOTH | Hoth Therapeutics, Inc. | 16.45M | 1.44% | 2,422,907 | - |
| 502 | COCP | Cocrystal Pharma, Inc. | 15.58M | -2.59% | 25,792 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 15.39M | -3.07% | 60,816 | - |
| 504 | APLT | Applied Therapeutics, Inc. | 15.29M | 0.40% | 67,785,193 | 1.00M |
| 505 | BCDA | BioCardia, Inc. | 14.86M | -1.41% | 33,527 | 3.00K |
| 506 | SNSE | Sensei Biotherapeutics, Inc. | 14.30M | -5.38% | 23,532 | - |
| 507 | TRAW | Traws Pharma, Inc. | 13.90M | -1.69% | 112,287 | 2.85M |
| 508 | SNGX | Soligenix, Inc. | 13.82M | -0.72% | 99,119 | 2.34K |
| 509 | NCNA | NuCana plc | 13.78M | -0.56% | 33,566 | - |
| 510 | SYBX | Synlogic, Inc. | 13.57M | 2.65% | 5,919 | 8.00K |
| 511 | AEON | AEON Biopharma, Inc. | 13.28M | 1.28% | 110,951 | - |
| 512 | MBRX | Moleculin Biotech, Inc. | 13.21M | 3.62% | 54,275 | - |
| 513 | GRDX | GridAI Technologies Corp. | 12.78M | -1.81% | 15,167 | - |
| 514 | BOLT | Bolt Biotherapeutics, Inc. | 12.67M | 2.33% | 23,155 | 5.20M |
| 515 | TPST | Tempest Therapeutics, Inc. | 12.47M | -0.78% | 76,160 | - |
| 516 | AKTX | Akari Therapeutics, Plc | 12.42M | 1.38% | 133,360 | - |
| 517 | BLRX | BioLineRx Ltd. | 12.41M | 1.05% | 4,310 | 12.74M |
| 518 | CRIS | Curis, Inc. | 12.14M | 3.85% | 221,292 | 11.65M |
| 519 | LGVN | Longeveron Inc. | 12.00M | 0.84% | 33,145 | 1.44M |
| 520 | EDSA | Edesa Biotech, Inc. | 11.89M | -1.62% | 25,514 | - |
| 521 | IMNN | Imunon, Inc. | 11.83M | -4.66% | 45,328 | - |
| 522 | PHIO | Phio Pharmaceuticals Corp. | 11.77M | -2.34% | 81,911 | - |
| 523 | GDTC | CytoMed Therapeutics Limited | 11.08M | 2.66% | 10,808 | 573.19K |
| 524 | NCEL | NewcelX Ltd. | 10.94M | -2.44% | 32,443 | - |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 10.81M | -0.79% | 18,152 | - |
| 526 | ABP | Abpro Holdings, Inc. | 10.48M | -0.90% | 8,332 | 183.00K |
| 527 | BRTX | BioRestorative Therapies, Inc. | 10.39M | -0.86% | 11,255 | 383.40K |
| 528 | INAB | IN8bio, Inc. | 10.24M | - | 13,749 | - |
| 529 | PMCB | PharmaCyte Biotech, Inc. | 10.13M | 9.29% | 354,115 | - |
| 530 | ERNA | Ernexa Therapeutics Inc. | 9.65M | -3.15% | 18,516 | 1,000.00 |
| 531 | PULM | Pulmatrix, Inc. | 9.48M | 9.55% | 15,437 | 3.00K |
| 532 | EVGN | Evogene Ltd. | 9.46M | 0.95% | 6,290 | 8.02M |
| 533 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.32M | -1.42% | 8,682 | - |
| 534 | ICU | SeaStar Medical Holding Corporation | 9.25M | -8.06% | 90,092 | 881.00K |
| 535 | BCTX | BriaCell Therapeutics Corp. | 9.15M | -6.38% | 693,175 | - |
| 536 | BIVI | BioVie Inc. | 8.89M | -2.48% | 94,870 | - |
| 537 | APVO | Aptevo Therapeutics Inc. | 8.78M | -2.28% | 32,517 | - |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.59M | -0.44% | 6,244 | - |
| 539 | IMRN | Immuron Limited | 8.49M | - | 31,504 | 4.78M |
| 540 | APM | Aptorum Group Limited | 8.39M | -2.83% | 115,304 | - |
| 541 | PCSA | Processa Pharmaceuticals, Inc. | 8.38M | 6.94% | 33,517 | - |
| 542 | ADXN | Addex Therapeutics Ltd | 8.23M | 0.12% | 599 | 198.82K |
| 543 | XTLB | XTL Biopharmaceuticals Ltd. | 8.10M | -5.05% | 226,191 | 968.00K |
| 544 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | -1.80% | 11,791 | 20.00K |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 7.90M | -3.57% | 25,620 | - |
| 546 | RNAZ | TransCode Therapeutics, Inc. | 7.83M | -5.32% | 1,165 | - |
| 547 | MBIO | Mustang Bio, Inc. | 7.74M | -1.85% | 40,737 | - |
| 548 | GTBP | GT Biopharma, Inc. | 7.65M | 9.02% | 7,636,047 | - |
| 549 | MTVA | MetaVia Inc. | 7.59M | -36.35% | 1,338,553 | - |
| 550 | TOVX | Theriva Biologics, Inc. | 7.27M | 1.64% | 682,265 | - |
| 551 | BGMS | Bio Green Med Solution, Inc. | 7.11M | 1.40% | 16,016 | 81.00K |
| 552 | SLXN | Silexion Therapeutics Corp | 7.10M | 7.08% | 66,253 | - |
| 553 | GNPX | Genprex, Inc. | 7.10M | 6.62% | 1,303,069 | - |
| 554 | PPBT | Purple Biotech Ltd | 7.07M | -3.64% | 43,961 | - |
| 555 | CELZ | Creative Medical Technology Holdings, Inc. | 6.71M | 3.78% | 35,502 | 6.00K |
| 556 | APRE | Aprea Therapeutics, Inc. | 6.50M | 3.33% | 13,472 | 488.24K |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 6.32M | -1.82% | 14,695 | - |
| 558 | ADIL | Adial Pharmaceuticals, Inc. | 6.15M | -0.85% | 123,134 | - |
| 559 | DCOY | Decoy Therapeutics Inc. | 6.07M | 9.21% | 1,274,685 | - |
| 560 | TCRT | Alaunos Therapeutics, Inc. | 6.03M | -1.46% | 8,826 | 6.00K |
| 561 | CANF | Can-Fite BioPharma Ltd. | 5.72M | -3.03% | 30,963 | 560.00K |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 5.55M | -4.01% | 73,420 | 2.86M |
| 563 | PPCB | Propanc Biopharma, Inc. | 5.38M | -5.07% | 141,872 | - |
| 564 | REVB | Revelation Biosciences, Inc. | 5.34M | 0.21% | 12,982 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 5.34M | -1.29% | 29,508 | - |
| 566 | VIVS | VivoSim Labs, Inc. | 5.28M | 0.75% | 12,571 | 140.00K |
| 567 | ASBP | Aspire Biopharma Holdings, Inc. | 5.20M | -17.55% | 21,023,424 | 1.94K |
| 568 | SILO | Silo Pharma, Inc. | 5.16M | -1.01% | 142,503 | 72.10K |
| 569 | XBIO | Xenetic Biosciences, Inc. | 5.13M | 1.36% | 4,457 | 2.86M |
| 570 | CNSP | CNS Pharmaceuticals, Inc. | 4.90M | 27.42% | 881,151 | - |
| 571 | GOVX | GeoVax Labs, Inc. | 4.84M | -1.40% | 112,626 | 3.35M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.61M | 1.40% | 3,027 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.38M | -2.81% | 68,231 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 4.22M | -0.71% | 30,990 | - |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.06M | -0.34% | 39,037 | - |
| 576 | PHGE | BiomX Inc. | 3.84M | -4.67% | 22,195 | - |
| 577 | OGEN | Oragenics, Inc. | 3.81M | -0.76% | 4,563 | - |
| 578 | CMND | Clearmind Medicine Inc. | 3.57M | -2.93% | 57,059 | - |
| 579 | ARTL | Artelo Biosciences, Inc. | 3.41M | 4.97% | 38,886 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.38M | 0.79% | 15,740 | 600.00K |
| 581 | SPRC | SciSparc Ltd. | 3.37M | -4.63% | 326,668 | 1.31M |
| 582 | GRI | GRI Bio, Inc. | 3.35M | 1.13% | 1,308,312 | - |
| 583 | JAGX | Jaguar Health, Inc. | 3.32M | -4.27% | 175,922 | 11.79M |
| 584 | ENSC | Ensysce Biosciences, Inc. | 3.31M | -2.15% | 30,811 | 4.49M |
| 585 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.29M | -1.10% | 44,005 | 15.78K |
| 586 | SCNI | Scinai Immunotherapeutics Ltd. | 3.19M | -4.11% | 42,714 | 1.15M |
| 587 | HCWB | HCW Biologics Inc. | 3.12M | 0.43% | 7,537 | 422.03K |
| 588 | BBLG | Bone Biologics Corporation | 3.00M | 3.73% | 35,933 | - |
| 589 | AZTR | Azitra, Inc. | 2.95M | -0.62% | 1,999,598 | 7.50K |
| 590 | DRMA | Dermata Therapeutics, Inc. | 2.75M | 6.36% | 128,630 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 2.46M | -0.54% | 104,660 | 2.99K |
| 592 | MLEC | Moolec Science SA | 2.43M | 157.51% | 3,904,225 | 7.83M |
| 593 | CDT | CDT Equity Inc. | 2.37M | -2.50% | 15,050 | - |
| 594 | ONCO | Onconetix, Inc. | 2.37M | -4.09% | 11,457 | 1.22M |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.07M | 2.73% | 1,057,575 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.85M | 5.74% | 71,112 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.30M | -10.88% | 364,690 | - |
| 598 | ADTX | Aditxt, Inc. | 1.30M | -0.01% | 84,352 | 5.95K |
| 599 | ELAB | PMGC Holdings Inc. | 829.69K | 25.28% | 461,215 | 285.95K |